Targepeutics

Biotechnology Research • Hershey, Pennsylvania, United States • 1-10 Employees

Company overview

Headquarters	475 West Govenor Rd., Hershey, PA 17033, US
Phone number	+17175712402
Website	targepeutics.com
NAICS	541714
SIC	873
Keywords	Cancer And Precision Medicine
Employees	1-10
Socials

Key Contact at Targepeutics

Lynn Maines

Vice President

Targepeutics Email Formats

Targepeutics uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@targepeutics.com), used 75% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@targepeutics.com	100%

About Targepeutics

Targepeutics is a biopharmaceutical company developing selective molecularly targeted therapeutics to fight and diagnose cancer and other diseases. Our lead compound, GB-13, is currently advancing toward a Phase I clinical trial for several cancer targets. GB-13 is a genetically engineered recombinant protein that specifically binds and destroys cancer cells with minimal normal cell damage. We have also licensed related technology for a cancer immunotherapy that is in Phase III clinical trials.

Targepeutics revenue & valuation

Annual revenue	$8,065,497
Revenue per employee	$1,614,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$25,900,000
Total funding	$200,000